Cargando…
The origins and genetic interactions of KRAS mutations are allele- and tissue-specific
Mutational activation of KRAS promotes the initiation and progression of cancers, especially in the colorectum, pancreas, lung, and blood plasma, with varying prevalence of specific activating missense mutations. Although epidemiological studies connect specific alleles to clinical outcomes, the mec...
Autores principales: | Cook, Joshua H., Melloni, Giorgio E. M., Gulhan, Doga C., Park, Peter J., Haigis, Kevin M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985210/ https://www.ncbi.nlm.nih.gov/pubmed/33753749 http://dx.doi.org/10.1038/s41467-021-22125-z |
Ejemplares similares
-
Optimized Multiplex Detection of 7 KRAS Mutations by Taqman Allele-Specific qPCR
por: Orue, Andrea, et al.
Publicado: (2016) -
Allele-Specific PCR for KRAS Mutation Detection Using Phosphoryl Guanidine Modified Primers
por: Chubarov, Alexey S., et al.
Publicado: (2020) -
KRAS mutant allele-specific expression knockdown in pancreatic cancer model with systemically delivered bi-shRNA KRAS lipoplex
por: Rao, Donald D., et al.
Publicado: (2018) -
KRAS variant allele frequency, but not mutation positivity, associates with survival of patients with pancreatic cancer
por: Suzuki, Tatsunori, et al.
Publicado: (2022) -
Wild-Type KRAS Allele Effects on Druggable Targets in KRAS Mutant Lung Adenocarcinomas
por: Baldelli, Elisa, et al.
Publicado: (2021)